tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Technical Analysis

1,293 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Coherus Biosciences’s (CHRS) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Coherus Biosciences is a Sell.
Coherus Biosciences’s (CHRS) 20-Day exponential moving average is 1.62, while Coherus Biosciences’s (CHRS) share price is $1.64, making it a Buy.
Coherus Biosciences’s (CHRS) 50-Day exponential moving average is 1.75, while Coherus Biosciences’s (CHRS) share price is $1.64, making it a Sell.

Coherus Biosciences (CHRS) Pivot Points

Jul 22, 2024, 08:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.32
1.43
1.50
1.61
1.68
1.79
1.86
Fibonacci
1.43
1.50
1.54
1.61
1.68
1.72
1.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Coherus Biosciences (CHRS) Moving Averages

Jul 22, 2024, 08:14 AM
Period
Simple
Exponential
MA5
1.68Sell
1.64Sell
MA10
1.58Buy
1.62Buy
MA20
1.58Buy
1.62Buy
MA50
1.77Sell
1.75Sell
MA100
2.02Sell
2.00Sell
MA200
2.32Sell
2.53Sell
Coherus Biosciences’s (CHRS) 10-Day exponential moving average is 1.62, while Coherus Biosciences’s (CHRS) share price is $1.64, making it a Buy.
Coherus Biosciences’s (CHRS) 100-Day exponential moving average is 2.00, while Coherus Biosciences’s (CHRS) share price is $1.64, making it a Sell.
Coherus Biosciences’s (CHRS) stock price is $1.64 and Coherus Biosciences’s (CHRS) 50-day simple moving average is 1.77, creating a Sell signal.
Coherus Biosciences’s (CHRS) stock price is $1.64 and Coherus Biosciences’s (CHRS) 100-day simple moving average is 2.02, creating a Sell signal.
Coherus Biosciences’s (CHRS) stock price is $1.64 and Coherus Biosciences’s (CHRS) 200-day simple moving average is 2.32, creating a Sell signal.

Coherus Biosciences (CHRS) Technical Indicators

Jul 22, 2024, 08:14 AM
Name
Value
Implied Action
RSI (14)
49.85
Neutral
STOCH (9,6)
60.42
Neutral
STOCHRSI (14)
61.07
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
23.75
Neutral
Williams %R
-40.46
Buy
CCI (14)
18.09
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
50.96
Neutral
ROC
-5.20
Sell
Coherus Biosciences’s (CHRS) Relative Strength Index (RSI) is 49.85, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Trend Strength Indicator (ADX) is 23.75, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Commodity Channel Index (CCI) is 18.09, creating a Neutral signal.
Coherus Biosciences’s (CHRS) Price Rate of Change (ROC) is -5.20, creating a Sell signal.

FAQ

Is CHRS a Buy, Hold, or Sell?
Based on CHRS’s technical indicators, CHRS is a Sell.
    What is CHRS’s RSI (14)?
    CHRS’s RSI (14) is 49.85, which suggests CHRS is a Neutral.
      What is CHRS’s MACD?
      CHRS’s MACD is -0.03, which suggests CHRS is a Sell.
        What is CHRS’s 5-day moving average?
        CHRS’s 5-day moving average is 1.68, which suggests CHRS is a Sell.
          What is CHRS’s 20-day moving average?
          CHRS 20-day moving average is 1.58, which suggests CHRS is a Buy.
            What is CHRS’s 50-day moving average?
            CHRS’s 50-day moving average is 1.77, which suggests CHRS is a Sell.
              What is CHRS’s 200-day moving average?
              CHRS’s 200-day moving average is 2.32, which suggests CHRS is a Sell.
                What is CHRS’s Williams % R (14)?
                CHRS’s Williams % R (14) is -40.46, which suggests CHRS is a Buy.
                  What is CHRS’s CCI (14)?
                  CHRS’s CCI (14) is 18.09, which suggests CHRS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis